NAS: HZNP
After Hours
--Quotes are delayed by 20 min
May 27, 2022, 5:17 p.m.
$
94.84
Change
0.00 0.00%
Volume
Volume 164,431
Quotes are delayed by 20 min
Previous close
$ 90.59
$ 94.84
Change
+4.25 +4.69%
Day low
Day high
$90.48
$94.86
52 week low
52 week high
$82.51
$120.54
Aaron L. Cox is Executive Vice President-Finance at Horizon Therapeutics Plc.
He received an MBA from The University of Chicago Booth School of Business and an undergraduate degree from the University of Notre Dame.
|
Mr. Timothy P. Walbert Chairman, President & Chief Executive Officer |
|
Mr. Aaron L. Cox Chief Financial Officer & Executive Vice President |
|
Dr. Karin Rosen Chief Scientific Officer |
|
Dr. Elizabeth H. Z. Thompson Executive Vice President-Research & Development |
|
Dr. Jeffrey W. Sherman Chief Medical Officer & Executive Vice President |
|
Mr. Michael A. DesJardin Executive VP-Technical Operations & Quality |
|
Dr. Jeffrey D. Kent Executive VP-Medical Affairs & Outcomes Research |
|
Mr. Andy Pasternak Chief Strategy Officer & Executive Vice President |
|
Ms. Holly Copeland Senior Director-Corporate Social Responsibility |
|
Ms. Marilyn Vetter Group Vice President-Market Access |
|
Mr. Vikram Karnani President-International & Executive Vice President |
|
Mr. Miles W. McHugh Chief Accounting Officer & Senior Vice President |
|
Ms. Tina Ventura Chief Investor Relations Officer & Senior VP |
|
Ms. Jane Gonnerman Chief of Staff & Group Vice President-Development |
|
Ms. Irina P. Konstantinovsky EVP, Chief Human Resources & Diversity Officer |
|
Mr. David Caraher Secretary |
|
Mr. Sean M. Clayton Executive Vice President & General Counsel |
|
Dr. Susan Mahony Independent Director |
|
Mr. Michael G. Grey Lead Independent Director |
|
Dr. Jeff Himawan Independent Director |
|
Mr. William Francis Daniel Independent Director |
|
Ms. Pascale Witz Independent Director |
|
Dr. James Samuel Shannon Independent Director |
|
Mr. H. Thomas Watkins Independent Director |
|
Mr. Gino Santini Independent Director |
Withdrawing from your 401(k) or IRA in a down market? What you need to know
Elon Musk says SpaceX accepting dogecoin ‘soon’, joining Tesla
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
The share of adults who say they would be able to cover a $400 emergency expense reaches 9-year high
Airlines face severe pilot shortage as summer travel season nears
War surges Norway’s oil, gas profit. Now, it’s urged to help
The S&P 500 may be finding a short-term bottom — but the intermediate worries remain
‘Lots of stagflation in the new home market’: Homebuilder ETFs are struggling
Alerts
Virtual Stock Exchange
Copyright © 2022 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Subscriber Agreement & Terms of Use
Privacy Notice and
Cookie Notice ().
Do Not Sell My Personal Information
Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.